Research summary ·
Ivabradine as a Treatment for Postural Orthostatic Tachycardia Syndrome: A Systematic Review.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This review looked at the drug ivabradine for people with POTS. Doctors use this drug for POTS outside its official use. The team searched for papers that tested this drug in POTS. They found 11 studies with 305 people, from 2008 to 2020. The papers used mixed methods, so results were told in words.
What they found
Only one study gave people the drug or a dummy pill by chance. That trial had 22 people. In it, the drug lowered heart rate more than the dummy pill. People also did better in physical and social functioning. All the studies pointed to a lower heart rate on the drug. One study used a POTS symptom score, and the total score got better. Gains were seen in feeling faint and light-headed when standing. Chest pain and the feeling of a fast heart rate also improved. Some studies listed side effects, such as a slow heart rate. Others were nausea, headache, tiredness, flushing and vision problems.
What it means for patients
The authors conclude the drug lowers heart rate and eases symptoms. But they rate the proof behind this as weak. They say the exact role of the drug in POTS is not yet clear.
Why it is not certain yet
The authors rated the evidence as low quality. Apart from 1 small trial, the studies only observed people. Some studies did not report side effects at all. The authors call for more trials of this drug. A review can only be as good as the studies in it.
Source
Ivabradine as a Treatment for Postural Orthostatic Tachycardia Syndrome: A Systematic Review.
PubMed · PMID 41364925We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Postural tachycardia syndrome (POTS) publications